KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Short term Debt: 2018-2024

Historic Short term Debt for Elanco Animal Health (ELAN) over the last 7 years, with Dec 2024 value amounting to $44.0 million.

  • Elanco Animal Health's Short term Debt rose 40.91% to $62.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.0 million, marking a year-over-year increase of 40.91%. This contributed to the annual value of $44.0 million for FY2024, which is 15.79% up from last year.
  • According to the latest figures from FY2024, Elanco Animal Health's Short term Debt is $44.0 million, which was up 15.79% from $38.0 million recorded in FY2023.
  • Elanco Animal Health's 5-year Short term Debt high stood at $555.0 million for FY2020, and its period low was $38.0 million during FY2023.
  • Over the past 3 years, Elanco Animal Health's median Short term Debt value was $44.0 million (recorded in 2024), while the average stood at $156.7 million.
  • Its Short term Debt has fluctuated over the past 5 years, first soared by 2,165.31% in 2020, then crashed by 90.21% in 2023.
  • Yearly analysis of 5 years shows Elanco Animal Health's Short term Debt stood at $555.0 million in 2020, then crashed by 47.03% to $294.0 million in 2021, then surged by 31.97% to $388.0 million in 2022, then crashed by 90.21% to $38.0 million in 2023, then rose by 15.79% to $44.0 million in 2024.